Novavax Inc

Founded in 1987, Novavax is a biotechnology company with its headquarters based in Gaithersburg, Maryland, United States. Specializing in the development of vaccines, Novavax plays a significant role in the biotechnology sector. Its most notable product, NVX-CoV2373—also known as Nuvaxovid or Covovax—is a protein-based COVID-19 vaccine that has garnered global attention. The influence of Novavax's products extends across numerous international markets, with its COVID-19 vaccine authorized for use in a range of territories, including the European Union, India, Indonesia, the Philippines, South Korea, and Canada. These approvals solidify Novavax's position as a key player in the global effort to combat the COVID-19 pandemic through immunization. (Powered by AI)